Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 11, 2014, Pages 3134-3141

  Fortun J ^a   Meije, Y ^a   Buitrago, M J ^b   Gago, S ^b   Bernal Martinez, L ^b   Peman J ^c   Perez M ^d   Gomez Ga Pedrosa E ^a   Madrid, N ^a   Pintado, V ^a   Martin Davila P ^a   Cobo, J ^a   Fresco, G ^a   Moreno, S ^a   Cuenca Estrella, M ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d Fontlab2000   (Spain)

Author keywords

B D glucan; CAGTA; Candida; PCR

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CREATININE; FLUCONAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLADDER CATHETERIZATION; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDEMIA; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FUNGUS CULTURE; GENE AMPLIFICATION; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASM; PARENTERAL NUTRITION; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS; TREATMENT DURATION; VALIDATION STUDY; ADOLESCENT; BLOOD; CANDIDIASIS, INVASIVE; CHILD; FEMALE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; STANDARDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDIASIS, INVASIVE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84916926830     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku225     Document Type: Article

References (33)

1. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3: 685-702.
2. Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
3. Shorr AF, Gupta V, Sun X et al. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med 2009; 37: 2519-26.
4. Fortún J, Martín-Dávila P, Gómez-García de la Pedrosa E et al. Emerging trends in candidemia: a higher incidence but a similar outcome. J Infect 2012; 65: 64-70.
5. Puig M, Garnacho J, Zaragoza R et al. Candida bloodstream infections (BSI) in the intensive care unit (ICU) adult patients. In: Abstracts of the Fifty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA, 2012. Abstract K-950. American Society for Microbiology, Washington, DC, USA.
6. Nguyen MH, Wissel MC, Shields RK et al. Performance of Candida real-time polymerase chain reaction, b-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54: 1240-8.
7. Groll AH, Shah PM, Mentzel C et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
8. Cuenca-Estrella M, Verweij PE, Arendrup MC et al. ESCMID guideline for the diagnosis and management of Candida diseases: diagnostic procedures. Clin Microbiol Infect 2012; 18 Suppl 7: 9-18.
9. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640-5.
10. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 2006; 25: 419-25.
11. GareyKW, Rege M, Pai MPet al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43: 25-31.
12. Ostrosky-Zeichner L, Pappas PG, Shoham S et al. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses 2011; 54: 46-51.
13. León C, Ruiz-Santana S, Saavedra P et al. Usefulness of the 'Candida score' for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 2009; 37: 1624-33.
14. Golan Y, Wolf MP, Pauker SG et al. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 2005; 143: 857-69.
15. Koo S, Bryar JM, Page JH et al. Diagnostic performance of the (1→3)-b-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009; 49: 1650-9.
16. Karageorgopoulos DE, Vouloumanou EK, Ntziora F et al. b-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011; 52: 750-70.
17. Moragues MD, Ortiz N, Iruretagoyena JR et al. Evaluation of a newcommercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm Infecc Microbiol Clin 2004; 22: 83-8.
18. Zaragoza R, Peman J, Quindos G et al. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin Microbiol Infect 2009; 15: 592-5.
19. Pemán J, Zaragoza R, Quindós G et al. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 2011; 11: 60.
20. Lau A, Halliday C, Chen SC et al. Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR. J Clin Microbiol 2010; 48: 811-6.
21. McMullan R, Metwally L, Coyle PV et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46: 890-6.
22. Wellinghausen N, Siegel D, Winter J et al. Rapid diagnosis of candidaemia by real-time PCR detection of Candida DNA in blood samples. J Med Microbiol 2009; 58: 1106-11.
23. Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 2011; 49: 665-70.
24. León C, Ruiz-Santana S, Saavedra P et al. Value of b-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Int Care Med 2012; 38: 1315-25.
25. Kasai M, Francesconi A, Petraitiene R et al. Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive candidiasis. J Clin Microbiol 2006; 44: 143-50.
26. Senn L, Robinson JO, Schmidt S et al. 1,3-b-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008; 46: 878-85.
27. Held J, Kohlberger I, Rappold E et al. Comparison of (1→3)-b-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol 2013; 51: 1158-64.
28. Hanson KE, Pfeiffer CD, Lease ED et al. b-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study. PLoS One 2012; 7: e42282.
29. Jaijakul S, Vazquez JA, Swanson RN et al. (1,3)-b-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis 2012; 55: 521-6.
30. Bougnoux M, Dupont C, Mateo J et al. Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR. J Clin Microbiol 1999; 37: 925-30.
31. Metwally L, Fairley DJ, Coyle PV et al. Comparison of serum and wholeblood specimens for the detection of Candida DNA in critically ill, nonneutropenic patients. J Med Microbiol 2008; 57: 1269-72.
32. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-b-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis 2007; 7: 103.
33. Guinea J, Zaragoza O, Escribano P et al. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011. Antimicrob Agents Chemother 2014; 58: 1529-37.